COVID-19 and immune checkpoint inhibitors: initial considerations

COVID-19 infections are characterized by inflammation of the lungs and other organs that ranges from mild and asymptomatic to fulminant and fatal. Patients who are immunocompromised and those with cardiopulmonary comorbidities appear to be particularly afflicted by this illness. During pandemic cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Ryan J, Johnson, Douglas B, Rini, Brian I, Neilan, Tomas G, Lovly, Christine M, Moslehi, Javid J, Reynolds, Kerry L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246104/
https://www.ncbi.nlm.nih.gov/pubmed/32434790
http://dx.doi.org/10.1136/jitc-2020-000933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246104/
https://www.ncbi.nlm.nih.gov/pubmed/32434790
http://dx.doi.org/10.1136/jitc-2020-000933

Ejemplares similares